Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
17 January 2014Website:
http://www.eksobionics.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:27:18 GMTDividend
Analysts recommendations
Institutional Ownership
EKSO Latest News
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso's Board
Ekso Bionics (EKSO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) will be hosting its Q1 2024 Results Conference Call on April 29, 2023 at 4:30 PM ET. Participants include Matt Steinberg, Scott Davis, Jerome Wong, and Jason Jones. Greetings and thank you for joining the Ekso Bionics' Q1 2024 Financial Results Call.
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wong - Chief Financial Officer Jason Jones - Chief Operating Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Ben Haynor - Alliance Global Partners Operator Greetings, and welcome to the Ekso Bionics' Fourth Quarter 2023 Financial Results Conference Call.
Ekso Bionics (EKSO) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.24 per share a year ago.
Ekso Bionics (EKSO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Ekso Bionics (NASDAQ: EKSO ) stock is on the rise Friday without any clear news from the exoskeleton company this morning. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today.
Ekso Bionics (EKSO) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.33 per share a year ago.
Ekso Bionics (EKSO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.23 per share a year ago.
Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript.
What type of business is Ekso Bionics Holdings?
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
What sector is Ekso Bionics Holdings in?
Ekso Bionics Holdings is in the Healthcare sector
What industry is Ekso Bionics Holdings in?
Ekso Bionics Holdings is in the Medical Instruments & Supplies industry
What country is Ekso Bionics Holdings from?
Ekso Bionics Holdings is headquartered in United States
When did Ekso Bionics Holdings go public?
Ekso Bionics Holdings initial public offering (IPO) was on 17 January 2014
What is Ekso Bionics Holdings website?
https://www.eksobionics.com
Is Ekso Bionics Holdings in the S&P 500?
No, Ekso Bionics Holdings is not included in the S&P 500 index
Is Ekso Bionics Holdings in the NASDAQ 100?
No, Ekso Bionics Holdings is not included in the NASDAQ 100 index
Is Ekso Bionics Holdings in the Dow Jones?
No, Ekso Bionics Holdings is not included in the Dow Jones index
When does Ekso Bionics Holdings report earnings?
The next expected earnings date for Ekso Bionics Holdings is 30 August 2024